Plant-based protein: Latest fad or long-term trend?

Assessing the growing popularity of meat-free alternatives

clock • 4 min read

Global investors are showing increasing interest in alternative protein sources, such as plant-based options and lab-grown meat.

The explosive IPO of Beyond Meat in May is a clear indicator of investor excitement around alternative proteins, although the company's subsequent drop in share price could point towards plant-based 'meat' as simply a marketing fad rather than a real investment trend.  Fuelling the uptake in alternative proteins is a rapid shift in our dietary habits, and it is not just the rise of veganism and vegetarianism, but also those who want to cut down on their meat intake, otherwise known as flexitarians. It is the latter group that are the real drivers of market demand for plant-based substitu...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot